ArticleInternational journal of hematology2024

CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity.

Shuki Oya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.